SYNOPSYS,INC. (NASDAQ:SNPS) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

0

SYNOPSYS,INC. (NASDAQ:SNPS) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Item5.02

Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.
(e) Amendment of 2006 Employee Equity Incentive Plan;
Approval of 2017 Non-Employee Directors Equity Incentive
Plan

At the 2017 Annual Meeting of Stockholders (the
Annual Meeting) of Synopsys, Inc.
(Synopsys) held on April6, 2017,
Synopsys stockholders approved Synopsys 2006 Employee Equity
Incentive Plan, as amended (the Amended Employee
Equity Plan
), in order to, among other items,
increase the number of shares of common stock available for
issuance under the plan by 5,000,000 shares. Synopsys Board of
Directors (the Board) and the
Compensation Committee of the Board previously approved the
Amended Employee Equity Plan, subject to such stockholder
approval. Synopsys executive officers are eligible to participate
in the Amended Employee Equity Plan.

At the 2017 Annual Meeting, Synopsys stockholders also approved
the 2017 Non-Employee Directors Equity Incentive Plan (the
Non-Employee Directors Equity Plan), in
order to, among other items, authorize 450,000 shares of common
stock for issuance under the plan. The Board and the Compensation
Committee previously approved the Non-Employee Directors Equity
Plan, subject to such stockholder approval. Only non-employee
members of the Board are eligible to participate in the
Non-Employee Directors Equity Plan.

Summaries of the Amended Employee Equity Plan and the
Non-Employee Directors Equity Plan are set forth in Synopsys
definitive proxy statement for the Annual Meeting filed with the
Securities and Exchange Commission on February17, 2017 (the
Proxy Statement). Those summaries and
the above descriptions of the Amended Employee Equity Plan and
Non-Employee Directors Equity Plan do not purport to be complete
and are qualified in their entirety by reference to the Amended
Employee Equity Plan and Non-Employee Directors Equity Plan,
which are filed as Exhibits 10.4 and 10.8, respectively, to this
Current Report on Form 8-K and are each incorporated herein by
reference.

Item5.07 Submission of Matters to a Vote of Security
Holders.

(a)(b) Stockholder Meeting
Results

As described in Item 5.02(e) above, Synopsys held its Annual
Meeting on April6, 2017. As of the record date, February10, 2017,
150,475,423 shares of Synopsys common stock were outstanding and
entitled to vote at the Annual Meeting. A total of 135,231,385
shares of Synopsys common stock, constituting a quorum, were
represented in person or by proxy at the Annual Meeting.

Synopsys stockholders voted on six proposals at the Annual
Meeting. The proposals are described in the Proxy Statement. The
final results of the votes regarding each proposal are set forth
below.

Proposal 1:Synopsys stockholders elected ten
directors to Synopsys Board, to serve until the next annual
meeting of stockholders or until their successors are elected.
The voting results regarding this proposal are set forth below:

For Withhold BrokerNon-Votes

Aart J. de Geus

119,073,106 6,428,657 9,729,622

Chi-Foon Chan

123,702,520 1,799,243 9,729,622

Janice D. Chaffin

125,259,491 242,272 9,729,622

Bruce R. Chizen

122,556,463 2,945,300 9,729,622

DeborahA.Coleman

116,735,273 8,766,490 9,729,622

Mercedes Johnson

117,524,501 7,977,262 9,729,622

Chrysostomos L. Max Nikias

124,643,547 858,216 9,729,622

John Schwarz

123,434,833 2,066,930 9,729,622

Roy Vallee

122,396,758 3,105,005 9,729,622

Steven C. Walske

117,492,867 8,008,896 9,729,622

Proposal 2:As described in Item 5.02(e) above,
Synopsys stockholders approved the Amended Employee Equity Plan
in order to, among other items, increase the number of shares of
common stock available for issuance under the plan by 5,000,000
shares. The Amended Employee Equity Plan is filed as Exhibit 10.4
to this Current Report on Form 8-K. The voting results
regarding this proposal are set forth below:

For:

113,172,919

Against:

12,242,912

Abstain:

85,932

Broker Non-Votes:

9,729,622

Proposal
3:
As described in Item 5.02(e) above, Synopsys
stockholders approved the Non-Employee Directors Equity Plan to
authorize 450,000 shares of common stock for issuance under the
plan. The Non-Employee Directors Equity Plan is filed as Exhibit
10.8 to this Current Report on Form 8-K. The voting results
regarding this proposal are set forth below:

For:

115,633,605

Against:

9,252,394

Abstain:

615,764

Broker Non-Votes:

9,729,622

Proposal
4:
Synopsys stockholders indicated their preference, on
an advisory basis, that an advisory vote on the compensation of
Synopsys named executive officers be held every year. The voting
results regarding this proposal are set forth below:

1 Year:

108,106,675

2 Years:

22,163

3 Years:

17,276,811

Abstain:

96,114

Proposal
5:
Synopsys stockholders approved, on an advisory basis,
the compensation of Synopsys named executive officers as
disclosed in the Proxy Statement. The voting results regarding
this proposal are set forth below:

For:

117,400,104

Against:

7,965,807

Abstain:

135,852

Broker Non-Votes:

9,729,622

Proposal
6:
Synopsys stockholders ratified the selection of KPMG
LLP as Synopsys independent registered public accounting firm for
the fiscal year ending October31, 2017. The voting results
regarding this proposal are set forth below:

For:

133,244,835

Against:

1,962,741

Abstain:

23,809
(d) Board Determination with Respect to Frequency of
Advisory Votes on Compensation

After
consideration of the results of the vote on Proposal 4 as
described above, and based upon current information and its prior
analysis and recommendation, on April 6, 2017 the Board
determined that Synopsys will hold an advisory vote on the
compensation of its named executive officers every year, until
the Board determines otherwise or Synopsys holds another advisory
vote on frequency, which will be no later than Synopsys 2023
Annual Meeting of Stockholders.

Item9.01 Financial Statements and Exhibits.
(d) Exhibits

Exhibit

Number

Description

10.4 2006 Employee Equity Incentive Plan, as amended
10.8 2017 Non-Employee Directors Equity Incentive Plan


About SYNOPSYS, INC. (NASDAQ:SNPS)

Synopsys, Inc. provides software, intellectual property (IP) and services. The Company supplies the electronic design automation (EDA) software that engineers use to design and test integrated circuits, also known as chips. It also offers IP products, which are pre-designed circuits that engineers use as components of larger chip designs rather than designing those circuits themselves. It provides software and hardware used to develop the electronic systems that incorporate chips and the software that runs on them. It provides technical services to support its solutions and help its customers develop chips and electronic systems. It is also a provider of software tools that developers use to develop software code in a range of industries, including electronics, financial services, energy, and industrials. It offers products and services in four categories: core EDA; IP, Systems and Software Integrity; Manufacturing Solutions, and Professional Services and Other.

SYNOPSYS, INC. (NASDAQ:SNPS) Recent Trading Information

SYNOPSYS, INC. (NASDAQ:SNPS) closed its last trading session down -0.12 at 71.34 with 743,455 shares trading hands.